JAK mutations in Down syndrome - associated transient myeloproliferative disorder and acute megakaryocytic leukemia

JAK mutations in Down syndrome - associated transient myeloproliferative disorder and acute megakaryocytic leukemia

Bibliographic Details
Main Authors:	Vyas, P, Crispino, J
Format:	Journal article
Language:	English
Published:	2008

Similar Items

Analysis of JAK3, JAK2, and C-MPL mutations in transient myeloproliferative disorder and myeloid leukemia of Down syndrome blasts in children with Down syndrome.
by: Norton, A, et al.
Published: (2007)

Analysis of GATA1 mutations in Down syndrome transient myeloproliferative disorder and myeloid leukemia.
by: Alford, K, et al.
Published: (2011)

Transient myeloproliferative disorder in Down′s syndrome
by: Vinayak Y Kshirsagar, et al.
Published: (2012-01-01)

Transient Myeloproliferative Disorder and Down Syndrome Is there a link?
by: Zenaida S. Reyes, et al.
Published: (2012-11-01)

Molecular insights into Down syndrome-associated leukemia.
by: Vyas, P, et al.
Published: (2007)

Acute megakaryoblastic leukaemia (AMKL) and transient myeloproliferative disorder (TMD) in Down syndrome: a multi-step model of myeloid leukaemogenesis.
by: Roy, A, et al.
Published: (2009)

GATA1 Mutation In Transient Leukemia (TL) and Myeloid Leukemia of Down Syndrome
by: Reinhardt, K, et al.
Published: (2010)

GATA1 Mutation In Transient Leukemia (TL) and Myeloid Leukemia of Down Syndrome
by: Reinhardt, K, et al.
Published: (2010)

A unique role of GATA1s in Down syndrome acute megakaryocytic leukemia biology and therapy.
by: Ana C Xavier, et al.
Published: (2011-01-01)

Stepwise GATA1 and SMC3 mutations alter megakaryocyte differentiation in a Down syndrome leukemia model
by: Brahim Arkoun, et al.
Published: (2023-04-01)

Acute leukemias in children with Down syndrome.
by: Zwaan, M, et al.
Published: (2008)

Acute leukemias in children with Down syndrome.
by: Zwaan, C, et al.
Published: (2010)

Atypical Presentation of Erythroid/Megakaryocytic Leukemic Transformation of a Myeloproliferative Neoplasm Associated with Mutation and Loss of TP53
by: Brian J. Chernak, et al.
Published: (2020-08-01)

The Mutation Profile of Calreticulin in Patients with Myeloproliferative Neoplasms and Acute Leukemia
by: Jingyi Wang, et al.
Published: (2016-08-01)

GATA1 mutation and trisomy 21 are required only in haematopoietic cells for development of transient myeloproliferative disorder.
by: Carpenter, E, et al.
Published: (2005)

Molecular cytogenetics for acute megakaryocytic leukemia diagnosis
by: E. A. Matveeva, et al.
Published: (2014-07-01)

Molecular cytogenetics for acute megakaryocytic leukemia diagnosis
by: E. A. Matveeva, et al.
Published: (2014-07-01)

Unbalanced chromosome 1 abnormalities leading to partial trisomy 1q in four infants with Down syndrome and acute megakaryocytic leukemia
by: Garcia Daniela, et al.
Published: (2009-02-01)

THE ROLE OF JAK2 MUTATION IN THROMBOTIC COMPLICATIONS OF CHRONIC MYELOPROLIFERATIVE NEOPLASMS
by: Viola M. Popov, et al.
Published: (2014-08-01)

Transient myeloproliferative disorder in a newborn with down syndrome treated with rasburicase for the risk of development of tumor lysis syndrome: A case report
by: Hatzistilianou Maria, et al.
Published: (2011-08-01)

Clinical meaning of JAK2 V617F mutation in chronic myeloproliferative disorders – the first experience
by: Joško Vučković, et al.
Published: (2006-10-01)

Frequent cases of RAS-mutated down syndrome acute lymphoblastic leukaemia lack JAK2 mutations
by: Nikolaev, Sergey I., et al.
Published: (2014)

Prognostic significance of mutated genes in megakaryocytic disorders
by: Ali Amin Asnafi, et al.
Published: (2019-07-01)

JAK2-V617F mutation in patients with myeloproliferative neoplasms: Association with FLT3-ITD mutation
by: Čolović Milica, et al.
Published: (2010-01-01)

A mutação JAK2 V617F e as síndromes mieloproliferativas JAK2 V617F mutation and the myeloproliferative disorders
by: Bárbara C. R. Monte-Mór, et al.
Published: (2008-01-01)

Myeloid pre-leukemia and leukemia of Down syndrome
by: Cruz Hernandez, D, et al.
Published: (2020)

The role of the Exon 13 G571S JAK2 mutation in myeloproliferative neoplasms
by: Burak Bahar, et al.
Published: (2016-01-01)

FREQUENCY OF MPL AND JAK2 EXON12 GENE MUTATION IN MYELOPROLIFERATIVE NEOPLASMS
by: Sana Latif, et al.
Published: (2020-06-01)

Sensitive, rapid diagnostic test for transient abnormal myelopoiesis and myeloid leukemia of Down syndrome
by: Cruz Hernandez, D, et al.
Published: (2020)

AXL Inhibition Extinguishes Primitive JAK2 Mutated Myeloproliferative Neoplasm Progenitor Cells
by: Stella Pearson, et al.
Published: (2019-06-01)

Analysis of JAK2 V617F mutation in Tunisian patients with myeloproliferative neoplasms
by: Soumaya Chadi, et al.
Published: (2021-04-01)

Recent insights into the mechanisms of myeloid leukemogenesis in Down syndrome.
by: Gurbuxani, S, et al.
Published: (2004)

1138 TGFβ-specific T cells recognize megakaryocyte progenitors in patients with myeloproliferative neoplasms
by: Vibe Skov, et al.
Published: (2023-11-01)

Megakaryocytic morphology in Janus kinase 2 V617F positive myeloproliferative neoplasm
by: Shuchi Ghai, et al.
Published: (2017-01-01)

Down syndrome preleukemia and leukemia.
by: Maloney, K, et al.
Published: (2014)

GATA1s induces hyperproliferation of eosinophil precursors in Down syndrome transient leukemia
by: Maroz, A, et al.
Published: (2014)

GATA1s induces hyperproliferation of eosinophil precursors in Down syndrome transient leukemia.
by: Maroz, A, et al.
Published: (2014)

Megakaryocytic Expansion in Gilteritinib-Treated Acute Myeloid Leukemia Patients Is Associated With AXL Inhibition
by: Kran Suknuntha, et al.
Published: (2020-12-01)

Myeloproliferative Neoplasms Associated with Mutation in JAK2V617F and Tyrosine Kinase Inhibitors as Therapeutic Strategy
by: Kaveh Tari, et al.
Published: (2015-04-01)

Trisomy 21 expands the megakaryocyte-erythroid progenitor compartment in human fetal liver-implications for down syndrome AMKL.
by: Tunstall-Pedoe, O, et al.
Published: (2006)